At Phico, we are developing a unique antibiotic technology to address one the most urgent challenges facing medicine today – how to destroy multi-drug resistant bacteria, the so-called “superbugs”.
Our patented platform utilises an antibacterial protein, SASP to inactivate bacterial DNA and cause rapid destruction of target bacteria. With a number of advantages over conventional antibiotic classes, SASPject™ could form the basis for a new generation of antibiotics to overcome antimicrobial resistance.
Watch our animation to discover how our technology works: https://www.youtube.com/channel/UCjPndK0F9ufmEy9fBQFTsUg
Twitter: @Phicotx
Youtube: Phico Therapeutics Ltd
Industry
Pharmaceutical Manufacturing, Raw materials for pharmaceuticals, Chemical base materials, Chemicals, Pharmaceuticals & Plastics
HQ Location
Bourn Hall,
High Street
Bourn, Cambridgeshire CB23 2TN, GB